(44- 20) 74 18 84 00 Fax (44- 20) 74 18 84 16 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2008 Reproduction and/ or distribution of this document is authorised for non- commercial or commercial purposes, provided the EMEA is acknowledged inosinmonofosfátdehydrogenázu.
El principio activo de Myfenax, el micofenolato mofetilo, es un medicamento inmunosupresor.